An engineered FGF21 variant, LY2405319, can prevent non-alcoholic steatohepatitis by enhancing hepatic mitochondrial function

Non-alcoholic fatty liver disease (NAFLD) is a prevalent obesity-related disease that affects large populations throughout the world due to excessive calorie intake and an increasingly sedentary lifestyle. Fibroblast growth factor 21 (FGF21) has recently emerged as a promising therapeutic candidate...

全面介紹

Na minha lista:
書目詳細資料
發表在:Am J Transl Res
Main Authors: Lee, Ju Hee, Kang, Yea Eun, Chang, Joon Young, Park, Ki Cheol, Kim, Hyeon-Woo, Kim, Jung Tae, Kim, Hyun Jin, Yi, Hyon-Seung, Shong, Minho, Chung, Hyo Kyun, Kim, Koon Soon
格式: Artigo
語言:Inglês
出版: e-Century Publishing Corporation 2016
主題:
Original Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5126319/
https://ncbi.nlm.nih.gov/pubmed/27904677
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍